AU50 50mg*10vials

AHK-Cu AU50 50mg*10vials

AHK-Cu is a modified copper-binding tripeptide (alanine-histidine-lysine) complexed with copper ions, designed with enhanced bioavailability for skin regeneration and tissue repair applications. It represents the highest-concentration research peptide in the AHK-Cu product line, designed for skin health and anti-aging studies.

The 50mg single-vial specification delivers five times the active ingredient content of the standard 10mg. This premium formulation is engineered for ultra-long-term skin regeneration studies, high-dose copper peptide validation experiments, and large-scale multi-group parallel research projects. The high concentration per vial eliminates repeated dilution steps across extended experimental timelines, reducing data deviation and operational errors from frequent solution preparation.

Through its copper-dependent enzyme activation, AHK-Cu supports comprehensive research into collagen synthesis, wound healing, skin rejuvenation, and tissue remodeling. It is designed to study how this modified copper peptide can promote skin health, support anti-aging benefits, and enhance tissue repair with improved bioavailability compared to standard copper peptides.

This product is supplied as sterile lyophilized powder in glass vials, formulated for reconstitution with bacteriostatic water. Each batch undergoes comprehensive purity testing, with a full certificate of analysis provided.

10 vials per pack, designed for top-tier professional research institutions and large-scale laboratory projects.